Acne Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1067287
  • December 2021
  • Healthcare
  • 125 Pages
Report Description

This report is a comprehensive study that examines the Acne industry in depth. With reference to key regions and major nations, the study specifies the product type of Acne as well as its use in various industrial verticals. Furthermore, the report identified and analysed all of the top companies functioning in the global Acne market arena, comparing and contrasting them based on market revenue, yearly sales volume, historical growth rate, and company strategies. The worldwide Acne market research offers a business strategy for current market participants to strengthen their market positions based on all of these findings. Furthermore, the paper recommends a market entry strategy for newcomers to the sector.

The top vendors and distributors operating in all of the major regions have also been highlighted in the Acne market report. This data and research should aid market players in strengthening their market distribution networks and expanding their geographic reach.
 
Acne Market Strategic Analysis 

The market was studied using several marketing methodologies such as Porter's Five Forces Analysis, player positioning analysis, SWOT analysis, market share analysis, and value chain analysis in the Acne market study. The market dynamics and factors such as the threat of a Acne substitute, the threat of new entrants into the Acne market, buyer bargaining power, supplier bargaining power to Acne providing companies, and internal rivalry among Acne providers are analysed in Porter's Five Forces analysis to provide the report's readers with a detailed view of the current market dynamics.

This analysis assists report users in evaluating the Acne market based on various parameters such as economies of scale, switching costs, brand loyalty, existing distribution channels, capital investments, manufacturing rights & patents, government regulations, advertising impact, and consumer preference impact. This simplified data is expected to aid the industry's key decision-makers in their decision-making process. Furthermore, this study answers the crucial question of whether or not new entrants should enter the Acne industry.
 
Acne Market Key Trends Analysis

The important factors influencing the growth of the Acne market have been examined in this report. The driving factors that are boosting demand for Acnes and the restraining factors that are slowing growth of the Acne industry are addressed in depth, as well as their implications for the worldwide Acne market. In addition, the published analysis identifies and discusses in detail the trends that are driving the market and impacting its growth. In addition, other qualitative variables such as risks connected with operations and key problems faced by market players are covered in the report.

Acne Market Key Segment Analysis

By segmenting the market by product type, application, and geography, the study provides a clear picture of the Acne industry. On the basis of current and future trends, all segments of the Acne industry have been examined. The market and its divisions are forecasted for the years 2021 through 2028. The study identifies the categories that are contributing the most to total market revenue growth, as well as the factors that are supporting their growth.

The research will provide a detailed qualitative and quantitative product type segment analysis for the years 2021 to 2028.

The report study analyses and includes a variety of prospective prospects and aspects affecting various applications.
 
Acne Market Regional Trends and Market Player’s Analysis

North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa are the regions in which the market is divided. In 2020, the worldwide Acne market was dominated by North America. The Asia Pacific region is expected to have the highest CAGR for the Acne market throughout the projected period.


 
The market revenue, market shares, business strategies, recent developments, and growth rates of major players with substantial market shares in the global Acne market are all examined. These firms' recent developments, such as new solution/product launches, research projects, acquisitions, geographic expansions, and technological advancements, are taken into account when determining their position in the Acne market. All important stakeholders in the Acne value chain and technological ecosystem are expected to benefit from the insights offered in the Acne market research study.

In order to provide a broader understanding of the top competitors in the Acne market, the research includes a company market share analysis. Allergan plc, Galderma S.A., Valeant Pharmaceutical International Inc., Teva Pharmaceutical Industries Ltd., Johnson & Johnson Services Inc., GlaxoSmithKline Plc., Bayer AG, Stiefel Laboratories Inc., Ranbaxy Laboratories Limited, Pfizer Inc., Sun Pharmaceutical Industries Limited, Mayne Pharma Group Limited, Mylan N.V., Cipher, Daiichi Sankyo Company Ltd, Guthy-Renker LLC, Medicis Pharmaceutical Corporation, Foamix Pharmaceuticals, BioPharmX Inc., Roche Holding AG, F. Hoffmann-la Roche Ltd, Anterios Inc., AndroScience, Oculus Innovative Sciences, Aqua Pharmaceuticals, Skinvisible Pharmaceuticals, Prestium Pharma Inc. are among the major participants in the global Acne industry.
 
Scope of the report
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2021
Forecast Period Covered 2021-2028
Units for value Revenue in USD million and CAGR from 2021 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Companies Covered Allergan plc, Galderma S.A., Valeant Pharmaceutical International Inc., Teva Pharmaceutical Industries Ltd., Johnson & Johnson Services Inc., GlaxoSmithKline Plc., Bayer AG, Stiefel Laboratories Inc., Ranbaxy Laboratories Limited, Pfizer Inc., Sun Pharmaceutical Industries Limited, Mayne Pharma Group Limited, Mylan N.V., Cipher, Daiichi Sankyo Company Ltd, Guthy-Renker LLC, Medicis Pharmaceutical Corporation, Foamix Pharmaceuticals, BioPharmX Inc., Roche Holding AG, F. Hoffmann-la Roche Ltd, Anterios Inc., AndroScience, Oculus Innovative Sciences, Aqua Pharmaceuticals, Skinvisible Pharmaceuticals, Prestium Pharma Inc.
 
Major Highlights of the Acne Market report study:
  • An in-depth examination of the global Acne industry will be published soon.
  • The study examines the global Acne market and offers major actionable information to its players.
  • The research has taken into account all key events in the recent past, providing users with up-to-date industry information.
  • The report study is expected to aid the industry's key decision-makers in their decision-making process.
  • Data on market intelligence, changing market dynamics, existing and predicted market trends, and so on are included in the report.
  • The research includes a detailed examination of the macroeconomic and microeconomic aspects that influence the global Acne industry.
  • The Market Ecosystem and Adoption in Different Markets
  • The global Acne market is being shaped by several major trends.
  • The size of the Acne market in terms of revenue has been measured in the past and will be measured in the future in USD million.
  • Consumer preference patterns and recent industrial developments
  • The worldwide Acne market's competitive landscape and player positioning analysis
  • Major players' key goods and solutions, as well as their business strategies
  • Recommendations for new market entrants as well as existing market participants.
  • The study of niche and potential segments (product type, application, and regions/countries) predicts that promising growth will be noticed.
  • Operating players in the market encounter a number of significant hurdles.
  • An examination of the major risks involved in market operations
 
The report segment of the global Acne market as follows:
Global Acne Market: By Product Type

  • Inflammatory Acne
  • Non-Inflammatory Acne

Global Acne Market: By Application
  • Hospitals & Clinics
  • Pharmacies & Drug Stores
  • Ambulatory Surgical Centres

Global Acne Market: By Region
  • North America
    • U.S.
    • Canada
    • Rest of North America
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China 
    • Japan
    • India
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

The report study is drafted to provide actionable insights to the following mentioned audience:
  • Institutes of research and consulting firms
  • Companies are attempting to get into the Acne market.
  • Universities and students
  • Other companies in the Acne market include solution providers, product producers, service providers, and others.
  • Private companies and government agencies that are linked
  • Individuals interested in learning more about the Acne market

Manufacturers and Segments

  • Allergan plc
  • Galderma S.A.
  • Valeant Pharmaceutical International Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Johnson & Johnson Services Inc.
  • GlaxoSmithKline Plc.
  • Bayer AG
  • Stiefel Laboratories Inc.
  • Ranbaxy Laboratories Limited
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Limited
  • Mayne Pharma Group Limited
  • Mylan N.V.
  • Cipher
  • Daiichi Sankyo Company Ltd
  • Guthy-Renker LLC
  • Medicis Pharmaceutical Corporation
  • Foamix Pharmaceuticals
  • BioPharmX Inc.
  • Roche Holding AG
  • F. Hoffmann-la Roche Ltd
  • Anterios Inc.
  • AndroScience
  • Oculus Innovative Sciences
  • Aqua Pharmaceuticals
  • Skinvisible Pharmaceuticals
  • Prestium Pharma Inc.
  • Inflammatory Acne
  • Non-Inflammatory Acne
  • Hospitals & Clinics
  • Pharmacies & Drug Stores
  • Ambulatory Surgical Centres

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Acne Market Snapshot
          2.1.1. Global Acne Market By Inflammatory Acne,2019
               2.1.1.1.
               2.1.1.2.Inflammatory Acne
          2.1.2. Global Acne Market By Hospitals & Clinics,2019
               2.1.2.1.
               2.1.2.2.Hospitals & Clinics
               2.1.2.3.Pharmacies & Drug Stores
          2.1.3. Global Acne Market By End-use,2019
          2.1.4. Global Acne Market By Geography,2019

3. Global Acne Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Acne Market Size (US$), By Inflammatory Acne, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Inflammatory Acne, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Inflammatory Acne, 2020
     4.2. Global Acne Market Size (US$), By Inflammatory Acne, 2018 – 2028

5. Global Acne Market Size (US$), By Hospitals & Clinics, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Hospitals & Clinics, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Hospitals & Clinics, 2020
     5.2. Global Acne Market Size (US$), By Hospitals & Clinics, 2018 – 2028

6. Global Acne Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Acne Market Size (US$), By End-use, 2018 – 2028

7. Global Acne Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Acne Market Analysis, 2018 – 2028 
          7.2.1. North America Acne Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Acne Market Size (US$), By Inflammatory Acne, 2018 – 2028
          7.2.3. North America Acne Market Size (US$), By Hospitals & Clinics, 2018 – 2028
          7.2.4. North America Acne Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Acne Market Analysis, 2018 – 2028 
          7.3.1.  Europe Acne Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Acne Market Size (US$), By Inflammatory Acne, 2018 – 2028
          7.3.3. Europe Acne Market Size (US$), By Hospitals & Clinics, 2018 – 2028
          7.3.4. Europe Acne Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Acne Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Acne Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Acne Market Size (US$), By Inflammatory Acne, 2018 – 2028
          7.4.3. Asia Pacific Acne Market Size (US$), By Hospitals & Clinics, 2018 – 2028
          7.4.4. Asia Pacific Acne Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Acne Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Acne Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Acne Market Size (US$), By Inflammatory Acne, 2018 – 2028
          7.5.3. Latin America Acne Market Size (US$), By Hospitals & Clinics, 2018 – 2028
          7.5.4. Latin America Acne Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Acne Market Analysis, 2018 – 2028 
          7.6.1.  MEA Acne Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Acne Market Size (US$), By Inflammatory Acne, 2018 – 2028
          7.6.3. MEA Acne Market Size (US$), By Hospitals & Clinics, 2018 – 2028
          7.6.4. MEA Acne Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Acne Providers
        8.4.1 Allergan plc
                8.4.1.1 Business Description
                8.4.1.2 Allergan plc Geographic Operations
                8.4.1.3 Allergan plc Financial Information
                8.4.1.4 Allergan plc Product Positions/Portfolio
                8.4.1.5 Allergan plc Key Developments
        8.4.2 Galderma S.A.
                8.4.2.1 Business Description
                8.4.2.2 Galderma S.A. Geographic Operations
                8.4.2.3 Galderma S.A. Financial Information
                8.4.2.4 Galderma S.A. Product Positions/Portfolio
                8.4.2.5 Galderma S.A. Key Developments
        8.4.3 Valeant Pharmaceutical International Inc.
                8.4.3.1 Business Description
                8.4.3.2 Valeant Pharmaceutical International Inc. Geographic Operations
                8.4.3.3 Valeant Pharmaceutical International Inc. Financial Information
                8.4.3.4 Valeant Pharmaceutical International Inc. Product Positions/Portfolio
                8.4.3.5 Valeant Pharmaceutical International Inc. Key Developments
        8.4.4 Teva Pharmaceutical Industries Ltd.
                8.4.4.1 Business Description
                8.4.4.2 Teva Pharmaceutical Industries Ltd. Geographic Operations
                8.4.4.3 Teva Pharmaceutical Industries Ltd. Financial Information
                8.4.4.4 Teva Pharmaceutical Industries Ltd. Product Positions/Portfolio
                8.4.4.5 Teva Pharmaceutical Industries Ltd. Key Developments
        8.4.5 Johnson & Johnson Services Inc.
                8.4.5.1 Business Description
                8.4.5.2 Johnson & Johnson Services Inc. Geographic Operations
                8.4.5.3 Johnson & Johnson Services Inc. Financial Information
                8.4.5.4 Johnson & Johnson Services Inc. Product Positions/Portfolio
                8.4.5.5 Johnson & Johnson Services Inc. Key Developments
        8.4.6 GlaxoSmithKline Plc.
                8.4.6.1 Business Description
                8.4.6.2 GlaxoSmithKline Plc. Geographic Operations
                8.4.6.3 GlaxoSmithKline Plc. Financial Information
                8.4.6.4 GlaxoSmithKline Plc. Product Positions/Portfolio
                8.4.6.5 GlaxoSmithKline Plc. Key Developments
        8.4.7 Bayer AG
                8.4.7.1 Business Description
                8.4.7.2 Bayer AG Geographic Operations
                8.4.7.3 Bayer AG Financial Information
                8.4.7.4 Bayer AG Product Positions/Portfolio
                8.4.7.5 Bayer AG Key Developments
        8.4.8 Stiefel Laboratories Inc.
                8.4.8.1 Business Description
                8.4.8.2 Stiefel Laboratories Inc. Geographic Operations
                8.4.8.3 Stiefel Laboratories Inc. Financial Information
                8.4.8.4 Stiefel Laboratories Inc. Product Positions/Portfolio
                8.4.8.5 Stiefel Laboratories Inc. Key Developments
        8.4.9 Ranbaxy Laboratories Limited
                8.4.9.1 Business Description
                8.4.9.2 Ranbaxy Laboratories Limited Geographic Operations
                8.4.9.3 Ranbaxy Laboratories Limited Financial Information
                8.4.9.4 Ranbaxy Laboratories Limited Product Positions/Portfolio
                8.4.9.5 Ranbaxy Laboratories Limited Key Developments
        8.4.10 Pfizer Inc.
                8.4.10.1 Business Description
                8.4.10.2 Pfizer Inc. Geographic Operations
                8.4.10.3 Pfizer Inc. Financial Information
                8.4.10.4 Pfizer Inc. Product Positions/Portfolio
                8.4.10.5 Pfizer Inc. Key Developments
        8.4.11 Sun Pharmaceutical Industries Limited
                8.4.11.1 Business Description
                8.4.11.2 Sun Pharmaceutical Industries Limited Geographic Operations
                8.4.11.3 Sun Pharmaceutical Industries Limited Financial Information
                8.4.11.4 Sun Pharmaceutical Industries Limited Product Positions/Portfolio
                8.4.11.5 Sun Pharmaceutical Industries Limited Key Developments
        8.4.12 Mayne Pharma Group Limited
                8.4.12.1 Business Description
                8.4.12.2 Mayne Pharma Group Limited Geographic Operations
                8.4.12.3 Mayne Pharma Group Limited Financial Information
                8.4.12.4 Mayne Pharma Group Limited Product Positions/Portfolio
                8.4.12.5 Mayne Pharma Group Limited Key Developments
        8.4.13 Mylan N.V.
                8.4.13.1 Business Description
                8.4.13.2 Mylan N.V. Geographic Operations
                8.4.13.3 Mylan N.V. Financial Information
                8.4.13.4 Mylan N.V. Product Positions/Portfolio
                8.4.13.5 Mylan N.V. Key Developments
        8.4.14 Cipher
                8.4.14.1 Business Description
                8.4.14.2 Cipher Geographic Operations
                8.4.14.3 Cipher Financial Information
                8.4.14.4 Cipher Product Positions/Portfolio
                8.4.14.5 Cipher Key Developments
        8.4.15 Daiichi Sankyo Company Ltd
                8.4.15.1 Business Description
                8.4.15.2 Daiichi Sankyo Company Ltd Geographic Operations
                8.4.15.3 Daiichi Sankyo Company Ltd Financial Information
                8.4.15.4 Daiichi Sankyo Company Ltd Product Positions/Portfolio
                8.4.15.5 Daiichi Sankyo Company Ltd Key Developments
        8.4.16 Guthy-Renker LLC
                8.4.16.1 Business Description
                8.4.16.2 Guthy-Renker LLC Geographic Operations
                8.4.16.3 Guthy-Renker LLC Financial Information
                8.4.16.4 Guthy-Renker LLC Product Positions/Portfolio
                8.4.16.5 Guthy-Renker LLC Key Developments
        8.4.17 Medicis Pharmaceutical Corporation
                8.4.17.1 Business Description
                8.4.17.2 Medicis Pharmaceutical Corporation Geographic Operations
                8.4.17.3 Medicis Pharmaceutical Corporation Financial Information
                8.4.17.4 Medicis Pharmaceutical Corporation Product Positions/Portfolio
                8.4.17.5 Medicis Pharmaceutical Corporation Key Developments
        8.4.18 Foamix Pharmaceuticals
                8.4.18.1 Business Description
                8.4.18.2 Foamix Pharmaceuticals Geographic Operations
                8.4.18.3 Foamix Pharmaceuticals Financial Information
                8.4.18.4 Foamix Pharmaceuticals Product Positions/Portfolio
                8.4.18.5 Foamix Pharmaceuticals Key Developments
        8.4.19 BioPharmX Inc.
                8.4.19.1 Business Description
                8.4.19.2 BioPharmX Inc. Geographic Operations
                8.4.19.3 BioPharmX Inc. Financial Information
                8.4.19.4 BioPharmX Inc. Product Positions/Portfolio
                8.4.19.5 BioPharmX Inc. Key Developments
        8.4.20 Roche Holding AG
                8.4.20.1 Business Description
                8.4.20.2 Roche Holding AG Geographic Operations
                8.4.20.3 Roche Holding AG Financial Information
                8.4.20.4 Roche Holding AG Product Positions/Portfolio
                8.4.20.5 Roche Holding AG Key Developments
        8.4.21 F. Hoffmann-la Roche Ltd
                8.4.21.1 Business Description
                8.4.21.2 F. Hoffmann-la Roche Ltd Geographic Operations
                8.4.21.3 F. Hoffmann-la Roche Ltd Financial Information
                8.4.21.4 F. Hoffmann-la Roche Ltd Product Positions/Portfolio
                8.4.21.5 F. Hoffmann-la Roche Ltd Key Developments
        8.4.22 Anterios Inc.
                8.4.22.1 Business Description
                8.4.22.2 Anterios Inc. Geographic Operations
                8.4.22.3 Anterios Inc. Financial Information
                8.4.22.4 Anterios Inc. Product Positions/Portfolio
                8.4.22.5 Anterios Inc. Key Developments
        8.4.23 AndroScience
                8.4.23.1 Business Description
                8.4.23.2 AndroScience Geographic Operations
                8.4.23.3 AndroScience Financial Information
                8.4.23.4 AndroScience Product Positions/Portfolio
                8.4.23.5 AndroScience Key Developments
        8.4.24 Oculus Innovative Sciences
                8.4.24.1 Business Description
                8.4.24.2 Oculus Innovative Sciences Geographic Operations
                8.4.24.3 Oculus Innovative Sciences Financial Information
                8.4.24.4 Oculus Innovative Sciences Product Positions/Portfolio
                8.4.24.5 Oculus Innovative Sciences Key Developments
        8.4.25 Aqua Pharmaceuticals
                8.4.25.1 Business Description
                8.4.25.2 Aqua Pharmaceuticals Geographic Operations
                8.4.25.3 Aqua Pharmaceuticals Financial Information
                8.4.25.4 Aqua Pharmaceuticals Product Positions/Portfolio
                8.4.25.5 Aqua Pharmaceuticals Key Developments
        8.4.26 Skinvisible Pharmaceuticals
                8.4.26.1 Business Description
                8.4.26.2 Skinvisible Pharmaceuticals Geographic Operations
                8.4.26.3 Skinvisible Pharmaceuticals Financial Information
                8.4.26.4 Skinvisible Pharmaceuticals Product Positions/Portfolio
                8.4.26.5 Skinvisible Pharmaceuticals Key Developments
        8.4.27 Prestium Pharma Inc.
                8.4.27.1 Business Description
                8.4.27.2 Prestium Pharma Inc. Geographic Operations
                8.4.27.3 Prestium Pharma Inc. Financial Information
                8.4.27.4 Prestium Pharma Inc. Product Positions/Portfolio
                8.4.27.5 Prestium Pharma Inc. Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Acne Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Acne Market Revenue, By Inflammatory Acne, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Acne Market Revenue, By Hospitals & Clinics, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Acne Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Acne Market Revenue, By Inflammatory Acne, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Acne Market Revenue, By Hospitals & Clinics, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Acne Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Acne Market Revenue, By Inflammatory Acne, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Acne Market Revenue, By Hospitals & Clinics, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Acne Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Acne Market Revenue, By Inflammatory Acne, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Acne Market Revenue, By Hospitals & Clinics, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Acne Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Acne Market Revenue, By Inflammatory Acne, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Acne Market Revenue, By Hospitals & Clinics, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Acne Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Acne: Market Segmentation 
FIG. 2 Global Acne Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Acne Market, By Inflammatory Acne, 2019 (US$ Mn) 
FIG. 5 Global Acne Market, By Hospitals & Clinics, 2019 (US$ Mn) 
FIG. 6 Global Acne Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Acne Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Acne Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Acne Providers, 2019
FIG. 11 Global Acne Market Revenue Contribution, By Inflammatory Acne, 2019 & 2028 (Value %) 
FIG. 12 Global Acne Market Revenue Contribution, By Hospitals & Clinics, 2019 & 2028 (Value %) 
FIG. 13 Global Acne Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Acne Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Acne Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Acne Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Acne Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Acne Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Acne market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Acne Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Acne Market Value, By Segment1, 2018 – 2028
TABLE  North America Acne Market Value, By Segment2, 2018 – 2028
TABLE  North America Acne Market Value, By Country, 2018 – 2028
TABLE  Europe Acne Market Value, By Segment1, 2018 – 2028
TABLE  Europe Acne Market Value, By Segment2, 2018 – 2028
TABLE  Europe Acne Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Acne Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Acne Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Acne Market Value, By Country, 2018 – 2028
TABLE  Latin America Acne Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Acne Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Acne Market Value, By Country, 2018 – 2028
TABLE  MEA Acne Market Value, By Segment1, 2018 – 2028
TABLE  MEA Acne Market Value, By Segment2, 2018 – 2028
TABLE  MEA Acne Market Value, By Country, 2018 – 2028
TABLE  Allergan plc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Galderma S.A.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Valeant Pharmaceutical International Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Teva Pharmaceutical Industries Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Johnson & Johnson Services Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  GlaxoSmithKline Plc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bayer AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Stiefel Laboratories Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Ranbaxy Laboratories Limited: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Pfizer Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Sun Pharmaceutical Industries Limited: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Mayne Pharma Group Limited: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Mylan N.V.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Cipher: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Daiichi Sankyo Company Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Guthy-Renker LLC: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Medicis Pharmaceutical Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Foamix Pharmaceuticals: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  BioPharmX Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Roche Holding AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  F. Hoffmann-la Roche Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Anterios Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  AndroScience: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Oculus Innovative Sciences: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Aqua Pharmaceuticals: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Skinvisible Pharmaceuticals: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Prestium Pharma Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Acne Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Acne Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Acne Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Acne Market, By Geography, 2019 (US$ Mn)
FIG.  Global Acne Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Acne Providers, 2016
FIG.  Global Acne Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Inflammatory Acne Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Non-Inflammatory Acne Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Acne Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Hospitals & Clinics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Pharmacies & Drug Stores Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Ambulatory Surgical Centres Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Acne Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Acne Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Acne Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Acne Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Acne Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Acne Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Acne Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Acne Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Acne Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Acne Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Acne Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Acne Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Acne Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Acne Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Acne Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Acne Market Value, 2018 – 2028, (US$ Mn)